TERZİ, H. And ERGÜL, M. 2019. In vitro comparison of cytotoxic effects of bortezomib resistant U266 myeloma cell line (U266/VELR) on combination of ibrutinib with carfilzomib and lenalidomid drugs. Cumhuriyet Medical Journal , vol.41, no.4 , 698-702.

TERZİ, H., & ERGÜL, M., (2019). In vitro comparison of cytotoxic effects of bortezomib resistant U266 myeloma cell line (U266/VELR) on combination of ibrutinib with carfilzomib and lenalidomid drugs. Cumhuriyet Medical Journal , vol.41, no.4, 698-702.

TERZİ, HATİCE, And MERVE ERGÜL. "In vitro comparison of cytotoxic effects of bortezomib resistant U266 myeloma cell line (U266/VELR) on combination of ibrutinib with carfilzomib and lenalidomid drugs," Cumhuriyet Medical Journal , vol.41, no.4, 698-702, 2019

TERZİ, HATİCE And ERGÜL, MERVE. "In vitro comparison of cytotoxic effects of bortezomib resistant U266 myeloma cell line (U266/VELR) on combination of ibrutinib with carfilzomib and lenalidomid drugs." Cumhuriyet Medical Journal , vol.41, no.4, pp.698-702, 2019

TERZİ, H. And ERGÜL, M. (2019) . "In vitro comparison of cytotoxic effects of bortezomib resistant U266 myeloma cell line (U266/VELR) on combination of ibrutinib with carfilzomib and lenalidomid drugs." Cumhuriyet Medical Journal , vol.41, no.4, pp.698-702.

@article{article, author={HATİCE TERZİ And author={MERVE ERGÜL}, title={In vitro comparison of cytotoxic effects of bortezomib resistant U266 myeloma cell line (U266/VELR) on combination of ibrutinib with carfilzomib and lenalidomid drugs}, journal={Cumhuriyet Medical Journal}, year=2019, pages={698-702} }